A detailed history of Monarch Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Monarch Capital Management Inc holds 760 shares of AMGN stock, worth $242,660. This represents 0.07% of its overall portfolio holdings.

Number of Shares
760
Previous 710 7.04%
Holding current value
$242,660
Previous $221,000 10.41%
% of portfolio
0.07%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$309.38 - $337.38 $15,469 - $16,869
50 Added 7.04%
760 $244,000
Q4 2023

Jan 17, 2024

BUY
$255.7 - $288.46 $181,547 - $204,806
710 New
710 $204,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Monarch Capital Management Inc Portfolio

Follow Monarch Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Capital Management Inc with notifications on news.